software Heidelberg eye explorer software version 6.9a) adhering to the OSCAR-IB quality control criteria and describing findings in accordance with the APOSTEL criteria [20, 21]
AgeMD's formulation is 5 mg/mL
DPP-4 inhibitors are oral medications that may be considered when type 2 diabetes needs more support, when another drug is not tolerated, or when a treatment plan needs to stay simple
Visible weight loss typically follows within the first month, with more significant results appearing around weeks 68 depending on dosage and consistency
Although some studies have shown positive results, others have reported no effects of GLP-1RAs
However, achievements of incretin-based therapies are often tempered by the need to maintain lifestyle changes and by gastrointestinal disturbances that compromise dose escalation, tolerability and adherence, indicating challenges for the design of future agents